Expert Panel Consensus Recommendations for Postoperative Pain Management in the Gulf Region

Abstract

Postoperative pain is a considerable issue in the Gulf region; however, at present there is a lack of comprehensive guidelines addressing postoperative pain management in the region. Therefore, an expert panel of pain specialists convened to address this issue and a set of key recommendations has been developed pertinent to the practice of postoperative pain management in the Gulf region (Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, the United Arab Emirates and Yemen). These recommendations take into consideration the unique variation in cultural, religious and societal beliefs found in the region, as well as varying accessibility to pain medications, thereby aiming to serve as evidence-based guidance on the best practice management of postoperative pain in the Gulf region.

KEYWORDS:

• COX-2 inhibitors
• Gulf region
• multimodal analgesia
• NSAIDs
• postoperative pain

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: http://www.tandfonline.com/doi/full/10.2217/pmt-2016-00

Financial & competing interests disclosure

The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer. SA Schug received travel expenses and an honorarium, paid to the University of Western Australia, for participating in the expert panel consensus meeting. Outside the submitted work, he has received travel expenses and honoraria, paid to the University of Western Australia, from bioCSL, Grünenthal, iX Biopharma, Mundipharma and Pfizer. He is also a member of PROSPECT, a scientific organization, which develops procedure-specific guidelines for postoperative pain management mentioned in the manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Editorial and writing support was provided by P Policarpio and C Facey of MIMS (Hong Kong) Limited and was funded by Pfizer.

Notes

Adapted with permission from [2].

Additional information

Funding

The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer. SA Schug received travel expenses and an honorarium, paid to the University of Western Australia, for participating in the expert panel consensus meeting. Outside the submitted work, he has received travel expenses and honoraria, paid to the University of Western Australia, from bioCSL, Grünenthal, iX Biopharma, Mundipharma and Pfizer. He is also a member of PROSPECT, a scientific organization, which develops procedure-specific guidelines for postoperative pain management mentioned in the manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Editorial and writing support was provided by P Policarpio and C Facey of MIMS (Hong Kong) Limited and was funded by Pfizer.